贝康医疗-B(02170)与RHEA LABS PTE. LTD订立战略合作协议，共同拓展美国、欧洲、南美和东南亚等地区的辅助生殖行业市场

智通财经02-25

智通财经APP讯，贝康医疗-B(02170)发布公告，本公司全资拥有的BMX Holdco Pte. Ltd.的全资子公司Genea Biomedx Pty Ltd.(Genea Biomedx)于2025年2月25日与Rhea Labs Pte. Ltd(Rhea Labs)订立了战略合作协议(战略合作协议)。该战略合作协议自签署日起生效，为期五年，旨在发挥双方商业优势的协同效应，共同拓展美国...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2514092894?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-25 22:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514092894","market":"sh","top_or_hot":-1,"title":"贝康医疗-B(02170)与RHEA LABS PTE. LTD订立战略合作协议，共同拓展美国、欧洲、南美和东南亚等地区的辅助生殖行业市场","media":"智通财经","content":"<div>\n<p>智通财经APP讯，贝康医疗-B(02170)发布公告，本公司全资拥有的BMX Holdco Pte. Ltd.的全资子公司Genea Biomedx Pty Ltd.(Genea Biomedx)于2025年2月25日 与Rhea Labs Pte. Ltd(Rhea Labs)订立了战略合作协议(战略合作协议)。该战略合作协议自签署日起生效，为期五年，旨在发挥双方商业优势的协同效应，共同拓展美国...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1254314.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>贝康医疗-B(02170)与RHEA LABS PTE. LTD订立战略合作协议，共同拓展美国、欧洲、南美和东南亚等地区的辅助生殖行业市场</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n贝康医疗-B(02170)与RHEA LABS PTE. LTD订立战略合作协议，共同拓展美国、欧洲、南美和东南亚等地区的辅助生殖行业市场\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-25 22:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1254314.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，贝康医疗-B(02170)发布公告，本公司全资拥有的BMX Holdco Pte. Ltd.的全资子公司Genea Biomedx Pty Ltd.(Genea Biomedx)于2025年2月25日 与Rhea Labs Pte. Ltd(Rhea Labs)订立了战略合作协议(战略合作协议)。该战略合作协议自签署日起生效，为期五年，旨在发挥双方商业优势的协同效应，共同拓展美国...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1254314.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"医疗保健用品","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1254314.html","article_id":"2514092894","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514092894","pubTimestamp":1740492034,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"董事会认为，战略合作协议将使本集团能够帮助本公司拓展销售渠道并加强其在辅助生殖技术市场的地位，因此符合本公司及其股东的整体利益。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1222":"医疗保健用品","PTE":"PolarityTE, Inc.","BK1574":"生物医药B类股","BK4139":"生物科技","02170":"贝康医疗-B","BK1597":"三胎概念"},"translate_title":"Becom Medical-B (02170) with RHEA LABS PTE. LTD entered into a strategic cooperation agreement to jointly expand the assisted reproduction industry market in the United States, Europe, South America and Southeast Asia","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PTE":1,"02170":1},"content_text":"智通财经APP讯，贝康医疗-B(02170)发布公告，本公司全资拥有的BMX Holdco Pte. Ltd.的全资子公司Genea Biomedx Pty Ltd.(Genea Biomedx)于2025年2月25日 与Rhea Labs Pte. Ltd(Rhea Labs)订立了战略合作协议(战略合作协议)。该战略合作协议自签署日起生效，为期五年，旨在发挥双方商业优势的协同效应，共同拓展美国、欧洲、南美和东南亚等地区的辅助生殖行业市场，打造人工智能赋能的标杆性试管婴儿(IVF)诊所。根据战略合作协议：(i) Genea Biomedx将向Rhea Labs提供高品质医疗产品及综合解决方案，支持Rhea Labs生殖机构建设，涵盖胚胎植入前基因检测(PGT)实验室、胚胎实验室、男科实验室、冷冻储存实验室等整体解决方案，以及适用于多种场景的各类辅助生殖中心设备，包括全时差培养箱(Geri®)和辅助生殖用液 (Gems);(ii) Rhea Labs和Genea Biomedx将在美国、欧洲、东南亚等地区共同推动品牌化建设;及(iii) Rhea Labs和Genea Biomedx将基于人工智能技术合作开发新产品。Rhea Labs是Rhea Fertility(瑞雅集团)的全资子公司，专注于辅助生殖领域数字技术的探索。Rhea Fertility主要事辅助生殖技术、妇科内分泌等与生育相关的服务，致力于推动女性保健解决方案的创新并打造全球垂直整合的生育业务。董事会认为，战略合作协议将使本集团能够帮助本公司拓展销售渠道并加强其在辅助生殖技术市场的地位，因此符合本公司及其股东的整体利益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514092894","isCrawlerRequest":true}